Joel Greenblatt - Gotham Asset Management
Holding/activity history for ImmunityBio, Inc. (IBRX)
← All IBRX superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 12,137 | <0.01 | Buy | <0.01 | $1.98–12.43 · VW $7.40i | $93,091 | SEC |
| 2025 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | $2.17–3.11 · VW $2.57i | SEC | |
| 2025 Q2 | 16,224 | <0.01 | Reduce 63.95% | <0.01 | $1.83–3.76 · VW $2.74i | $42,831 | SEC |
| 2025 Q1 | 45,005 | <0.01 | Buy | <0.01 | $2.28–4.27 · VW $3.21i | $135,465 | SEC |
| 2024 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | $3.23–6.84 · VW $4.42i | SEC | |
| 2024 Q2 | 14,594 | <0.01 | Reduce 55.13% | <0.01 | $4.73–10.53 · VW $7.47i | $92,234 | SEC |
| 2024 Q1 | 32,526 | <0.01 | Add 201.50% | <0.01 | $3.12–6.78 · VW $4.68i | $174,665 | SEC |
| 2023 Q4 | 10,788 | <0.01 | Buy | <0.01 | $1.25–5.28 · VW $3.42i | $54,156 | SEC |
Price snapshot:
Current price$7.79
Avg. buy price$7.67
+/- since buy1.56%
52-week low$1.95
52-week high$12.43